IMMUNE INSIGHTS
Imperial’s human challenge study helps explain why some people don’t get COVID
New analysis based on Imperial’s COVID-19 human challenge study has helped to uncover how some people avoid getting sick.
Stories tagged with 'Infectious diseases'
NEW CBRB DIRECTORS
Imperial’s CBRB appoints new co-directors
Professor Mariagrazia Pizza and Professor Shiranee Sriskandan will lead the Centre for Bacterial Resistance Biology (CBRB).
Summer Meeting 2024
Network Summer Meeting 2024
All day Summer Meeting spanning fungal biotechnologies, food security and human health.
Fighting AMR
GSK backs Imperial’s Fleming Initiative with £45m pledge to fight AMR
GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally.
Infectious Insights
Analysis reveals new insights into global surge of Strep A infections
New analysis has revealed more about the origins of the main bacterial strain involved in an increase in lethal cases.
Project kick-off
Imperial-led global human challenge consortium kick off ambitious 5-year project
On 17-18 April, an international group of researchers specialising in human challenge studies convened at Imperial College London.
Blood markers
Long COVID leaves telltale traces in the blood
People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.
5
Feature
Bench to bedside
Eight things we learned about commercialising medical research at AYCI 2024
We learnt why you should channel Mary Somerville, how timing can make or break a startup, and other lessons from experts at All You Can Innovate 2024.
Infection studies
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
Impact of AI on AMR
Impact of artificial intelligence on AMR: Common themes and challenges
Researchers gather to explore visions, themes & challenges around the use of Artificial Intelligence (AI) to tackle antimicrobial resistance (AMR).
